Endovasc, Inc.

Endovasc, Inc. is out of business. It engages in the development and commercialization of drugs in the areas of cardiovascular and metabolic medicine. The company holds licenses and patents related to liposomes, stent coatings, and biodegradable/resorbable prostheses for the treatment of vascular dysfunction and heart disease. The company's trademark products include Liprostin; and PROStent. The company was incorporated in 1996 and is based in Montgomery, Texas. On February 3, 2008, Endovasc, Inc. filed a voluntary petition for liquidation under Chapter 7 in the US Bankruptcy Court for the Southern District of Texas.